Samuel Whiting

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
South San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Nicholas Maestas, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Samuel Whiting

Form 4 holding Chief Medical Officer

Tempest Therapeutics, Inc.

Security class
Common Stock
Shares / value
9,573
Estimated value
$20,390
Report date
02 Jul 2024
Price
$2.13
Ownership
Direct
Form 4 holding Chief Medical Officer

Tempest Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
270,000
Estimated value
Report date
02 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Samuel Whiting

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .